Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cost-effectiveness analysis of core decompression.

Nelson Fong Soohoo1, Shail Vyas, Jesse Manunga

  • 1UCLA School of Medicine, Department of Orthopaedic Surgery, Los Angeles, California 90095, USA.

The Journal of Arthroplasty
|August 1, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reassessing Total Joint Arthroplasty Case Volumes in The United States: Accounting for Ultra-Low-Volume Surgeons.

The Journal of arthroplasty·2026
Same author

Long-term Outcomes of Patients with Failed Abdominal Aortic Aneurysm Repairs Rescued Using Fenestrated/Branched Stent-grafts at Centers without Access to Custom-made Devices.

Journal of vascular surgery·2026
Same author

Neutrophil-Lymphocyte Ratio Trajectories Predict Mortality and Medical Complications in Hip Fracture Patients Undergoing Hemiarthroplasty.

The Journal of arthroplasty·2026
Same author

Transfusions are Associated with an Elevated Risk of Venous Thromboembolism and Periprosthetic Joint Infection following Revision Total Knee Arthroplasty.

The Journal of arthroplasty·2026
Same author

Use of Home Spirometry for Steroid Tapering.

Respirology case reports·2026
Same author

Factor XI and XIa Inhibitors for Venous Thromboembolism Prophylaxis After Total Knee Arthroplasty: A Review From Mechanism to Phase III Trials.

The Journal of arthroplasty·2026

Core decompression for osteonecrosis of the hip is cost-effective if it delays total hip arthroplasty by at least 5 years. This finding aids orthopedic surgeons in evaluating treatment efficacy and economic value for femoral head osteonecrosis.

Area of Science:

  • Orthopedics
  • Health Economics
  • Biomedical Engineering

Background:

  • Core decompression is a common treatment for early-stage osteonecrosis of the hip.
  • Evaluating the cost-effectiveness of medical interventions is crucial for healthcare providers.
  • Osteonecrosis of the femoral head can lead to significant morbidity and the need for joint replacement.

Purpose of the Study:

  • To assess the cost-effectiveness of core decompression for osteonecrosis of the femoral head.
  • To provide orthopedic surgeons with data-driven insights for treatment decisions.
  • To determine the threshold for cost-effectiveness based on delaying total hip arthroplasty.

Main Methods:

  • Development of a decision model for osteonecrosis of the femoral head treatment.

Related Experiment Videos

  • Comprehensive literature review to identify treatment outcomes and probabilities.
  • Analysis of the incremental cost-effectiveness ratio (ICER) for core decompression versus observation.

    • Main Results:

    • Core decompression requires a minimum 5-year delay in total hip arthroplasty to achieve an ICER below $50,000 per quality-adjusted life year.
    • Treatment options exceeding $50,000/QALY are generally considered to have limited cost-effectiveness.
    • The study highlights the potential for core decompression to be highly cost-effective under specific conditions.

    Conclusions:

    • Core decompression can be a cost-effective intervention for osteonecrosis of the hip.
    • The economic viability of core decompression is contingent upon delaying the need for total hip arthroplasty by 5 years or more.
    • This analysis supports informed decision-making regarding the use of core decompression in managing femoral head osteonecrosis.